the-124

Unknown Manufacturer

Generate AI report

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

MIR-124 AS A BIOMARKER FOR THE TREATMENT OF INFLAMMATORY DISEASES
EP 3998070 B1Applicant: ABIVAXPriority: 2014
CN
EP
US
12 publications
Polynucleotides and polypeptides involved in plant fiber development and methods of using same
US 7812218 B2Applicant: EVOGENE LTDPriority: 2004
CN
US
9 publications
TRANSPOSASE MUTANT WITH ENHANCED EFFICIENCY OF GENE TRANSFER
EP 4353821 A1Applicant: MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFTPriority: 2022
CN
EP
US
WO
5 publications
QUINOLINE DERIVATIVE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF
US 20260216180 A1Applicant: JIANGSU CAREPHAR PHARMACEUTICAL CO LTDPriority: 2023
CN
EP
US
WO
5 publications
Methods of differentiating stem cells by modulating MIR-124
US 9457053 B2Applicant: ACCELERATED BIOSCIENCES CORPPriority: 2012
CN
US
5 publications
TACE NAVIGATION GUIDANCE BASED ON TUMOR VIABILITY AND VASCULAR GEOMETRY
EP 3203913 A1Applicant: KONINKLIJKE PHILIPS NVPriority: 2014
CN
EP
US
WO
4 publications
TRANSCRIPTIONAL AND TRANSLATIONAL DUAL REGULATED ONCOLYTIC HERPES SIMPLEX VIRUS VECTORS
- EP 4469587 A4
  Applicant: VIROGIN BIOTECH CANADA LTDPriority: 2022
  CN
  EP
  US
  WO
  4 publications
- EP 4313094 A4
  Applicant: VIROGIN BIOTECH CANADA LTDPriority: 2021
  EP
  US
  WO
  3 publications
TREATMENT OF CANCERS AND INFECTIOUS DISEASES WITH KILLED INTACT BACTERIA
EP 4619016 A4Applicant: INDAPTUS THERAPEUTICS INCPriority: 2022
CN
EP
US
WO
4 publications
MIR-124 INDUCER, AND PREPARATION METHOD THEREFOR AND USE THEREOF
EP 4667460 A1Applicant: NANJING SYNNOCARE PHARMACEUTICAL TECH CO LTDPriority: 2023
CN
EP
US
WO
4 publications
Wnt7 variants capable of activating g-protein coupled receptor (Gpr)124/Reck/frizzled/lipoprotein receptor-related protein (LRP)-mediated Wnt signaling
US 11840557 B2Applicant: UNIV BRUXELLESPriority: 2018
CN
EP
US
4 publications

Drugs

the-124

Patents

TRANSCRIPTIONAL AND TRANSLATIONAL DUAL REGULATED ONCOLYTIC HERPES SIMPLEX VIRUS VECTORS